Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma

  • Egil S Blix1, 2Email author,
  • Jonathan M Irish3, 4,
  • Anne Husebekk5,
  • Jan Delabie6,
  • Lise Forfang7,
  • Anne M Tierens6,
  • June H Myklebust7 and
  • Arne Kolstad8
Contributed equally
BMC Cancer201212:478

DOI: 10.1186/1471-2407-12-478

Received: 23 April 2012

Accepted: 12 October 2012

Published: 16 October 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
23 Apr 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
19 Jun 2012 Reviewed Reviewer Report - Stefania Gobessi
30 Sep 2012 Reviewed Reviewer Report - Giovanni Carulli
10 Oct 2012 Author responded Author comments - Egil Blix
Resubmission - Version 3
10 Oct 2012 Submitted Manuscript version 3
Publishing
12 Oct 2012 Editorially accepted
16 Oct 2012 Article published 10.1186/1471-2407-12-478

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Oncology, University Hospital of North Norway
(2)
Immunology Research group, Institute of Medical Biology, University of Tromsø
(3)
Department of Medicine, Oncology Division, Stanford University
(4)
Department of Microbiology and Immunology, Baxter Laboratory of Genetic Pharmacology, Stanford University
(5)
Department of Laboratory Medicine, University Hospital North Norway
(6)
Department of Pathology, Division of Cancer Medicine and Surgery, Oslo University Hospital
(7)
Institute for Cancer Research, Oslo University Hospital and Centre for Cancer Biomedicine
(8)
Department of Oncology, Norwegian Radium Hospital, Oslo University Hospital

Advertisement